³ÉÈËVRÊÓƵ

In its 2016 financial results press release, Mississauga-based Profound Medical announced the appointment of Samira Sakhia (BCom’90, MBA’01) to its Board of Directors. Ms. Sakhia is also a member of the and serves as President of Knight Therapeutics. Prior to that, she was CFO of Paladin Labs, which she helped sell to Dublin-based pharma giant, Endo International.

Ms. Sakhia’s appointment to the Board comes on the heels of the resignation of Jonathan Ross Goodman, who played an important role in taking the company public.

Read full article: , March 7, 2017